These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 33759279)
1. Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study. Sisakht M; Mahmoodzadeh A; Darabian M Phytother Res; 2021 Jun; 35(6):3262-3274. PubMed ID: 33759279 [TBL] [Abstract][Full Text] [Related]
2. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2. Abdizadeh R; Hadizadeh F; Abdizadeh T Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of phytoconstituents of Choudhary P; Singh T; Amod A; Singh S J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486 [TBL] [Abstract][Full Text] [Related]
7. Exploring the Therapeutic Potential of Ali MA; Sheikh H; Yaseen M; Faruqe MO; Ullah I; Kumar N; Bhat MA; Mollah MNH Molecules; 2024 May; 29(11):. PubMed ID: 38893400 [TBL] [Abstract][Full Text] [Related]
8. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods. Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552 [TBL] [Abstract][Full Text] [Related]
9. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Gupta Y; Kumar S; Zak SE; Jones KA; Upadhyay C; Sharma N; Azizi SA; Kathayat RS; Poonam ; Herbert AS; Durvasula R; Dickinson BC; Dye JM; Rathi B; Kempaiah P Bioorg Med Chem; 2021 Oct; 47():116393. PubMed ID: 34509862 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies. Abdizadeh R; Hadizadeh F; Abdizadeh T J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354 [TBL] [Abstract][Full Text] [Related]
11. Finding potent inhibitors against SARS-CoV-2 main protease through virtual screening, ADMET, and molecular dynamics simulation studies. Roy R; Sk MF; Jonniya NA; Poddar S; Kar P J Biomol Struct Dyn; 2022 Sep; 40(14):6556-6568. PubMed ID: 33682642 [TBL] [Abstract][Full Text] [Related]
12. Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19. Kumar Tiwari P; Chouhan M; Mishra R; Gupta S; Chaudhary AA; Al-Zharani M; Ahmed Qurtam A; Nasr FA; Jha NK; Pant K; Kumar M; Kumar S Front Cell Infect Microbiol; 2024; 14():1391288. PubMed ID: 38919703 [TBL] [Abstract][Full Text] [Related]
13. Virtual Screening of Miandad K; Ullah A; Bashir K; Khan S; Abideen SA; Shaker B; Alharbi M; Alshammari A; Ali M; Haleem A; Ahmad S Molecules; 2022 Nov; 27(22):. PubMed ID: 36432204 [TBL] [Abstract][Full Text] [Related]
14. Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (M Patel CN; Jani SP; Jaiswal DG; Kumar SP; Mangukia N; Parmar RM; Rawal RM; Pandya HA Sci Rep; 2021 Oct; 11(1):20295. PubMed ID: 34645849 [TBL] [Abstract][Full Text] [Related]
16. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies. Azeem M; Mustafa G; Mahrosh HS Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514 [TBL] [Abstract][Full Text] [Related]
17. ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19. Fakhar Z; Khan S; AlOmar SY; Alkhuriji A; Ahmad A Sci Rep; 2021 Jan; 11(1):234. PubMed ID: 33420186 [TBL] [Abstract][Full Text] [Related]